U.S. Compounding Pharmacies Market size to exceed USD 7 bn by 2025

U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.

Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured drugs in the market will surge the demand of compounded drugs. Timely availability of compounded drugs in the treatment of cardiac or other emergency conditions will thus foster the U.S. compounding pharmacies industry growth.


Request Sample Buy NowInquiry Before Buying


Rise in the number of baby boomers susceptible to various chronic and non-communicable disease will render positive impact in the market growth. Ability of compounding pharmacies to formulate liquid dosage for patients with difficulty in swallowing pills and combine certain prescriptions into single dose enables patients to avoid administration of multiple doses. However, safety issues pertaining to compounded drugs coupled with continuously changing regulatory scenario may hamper the adoption of compounded medication thereby rendering negative impact on the business growth.


U.S. Compounding Pharmacies Market, 2014 – 2025 (USD Billion)
U.S. Compounding Pharmacies Market

Get more details on this report - Request Free Sample PDF

503B compounding pharmacy segment accounted for USD 2.5 billion in 2017 and is estimated to show lucrative growth over analysis period. The growth is attributable to the ability of these pharmacies to compound mass medication, thereby lowering production costs and increasing customer base.

Browse key industry insights spread across 110 pages with 14 market data tables & 11 figures & charts from the report, “U.S. Compounding Pharmacies Market Size By Pharmacy Type (503A, 503B), By Sterility (Sterile, Non-sterile), By Product (Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, Otic), By Application (Pediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Specialty Drugs, Nutritional Supplements), Application Potential, Competitive Market Share & Forecast, 2018 - 2025” in detail along with the table of contents:

Non-sterile segment held the highest share of 67.7% in 2017 owing to increasing adoption of oral medication that offers convenience and ease of administration in patients of all age groups. Growing demand for oral liquid preparation and topical medication for pain management and anti-inflammatory therapies will further propel segment growth.

Topical product segment is estimated to witness 5.3% CAGR over the analysis timeframe owing to increasing demand for topically administered drugs such as muscle relaxants, anti-inflammatories and anesthetics prescribed for pain management and inflammation therapy.

Pediatric application segment held 14.5% market share in 2017 and is estimated to grow significantly during the forthcoming years. Ability of compounding pharmacies to transform standard drugs into flavored dosage and colorful forms will increase its acceptance among the children thereby accelerating the segmental growth.

Pharmaceutical ingredient alteration (PIA) segment accounted for USD 1.7 billion in 2017 owing to rising demand for drugs compounded in accordance with specific patient needs such as hypoallergenic versions of drugs for individuals allergic to certain dyes or preservatives.

Hormone replacement therapeutic segment is anticipated to show CAGR of 5.3% over the forecast period. Compounded hormone replacement therapy can be used specifically to suit individual body and hormone levels. Growing awareness among women regarding compounded bioidentical menopausal hormone therapy (BMHT) will further spur the segment growth.

Some of the prominent players operating in U.S. compounding pharmacies market are Absolute Pharmacy, B. Braun Medical, Baxter, Cantrell Drug Company, Central Compounding Center, Clinigen Group, Dougherty’s Pharmacy, Fagron, Fresenius Kabi, ICU Medical, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, McGuff Compounding Pharmacy Services, McKesson Corporation, Nephron Pharmaceuticals, Pencol Compounding Pharmacy, Pentec Health, PharMEDium, Premier Pharmacy Labs, Rx3 Compounding Pharmacy, RXQ Compounding Pharmacy, Triangle Compounding Pharmacies, Wedgewood Village Pharmacy and Wells Pharmacy Network. Key industry players are majorly focusing on mergers and acquisitions to broaden product portfolio and capture high revenue share.

Inquiry Before BuyingRequest Sample

U.S. Compounding Pharmacies Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

U.S. compounding pharmacies market, by pharmacy type

  • 503A compounding pharmacy
  • 503B compounding pharmacy

U.S. compounding pharmacies market, by sterility

  • Sterile
  • Non-sterile

U.S. compounding pharmacies market, by product

  • Oral
    • Solid preparations
      • Tablets
      • Capsules
      • Granules
      • Powder
      • Others
    • Liquid preparations
      • Solutions
      • Suspension
      • Emulsion
      • Syrup
      • Others
  • Topical
    • Ointments
    • Creams
    • Gels
    • Pastes
    • Others
  • Rectal
    • Suppositories
    • Enema
    • Others
  • Parenteral
    • Large volume parenteral (LVP)
    • Small volume parenteral (SVP)
  • Nasal
  • Ophthalmic
  • Otic

U.S. compounding pharmacies market, by application

  • Pediatric
  • Adult
  • Geriatric
  • Veterinary

U.S. compounding pharmacies market, by compounding type

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

U.S. compounding pharmacies market, by therapeutic area

  • Hormone Replacement
  • Pain Management
  • Dermatology
  • Specialty Drugs
  • Nutritional Supplements
  • Others

LSI Keywords

  • Bulk Compounding Pharmacy Market
  • Pharmaceutical Compounding Market
  • Veterinary Compounding Pharmacy Market
  • Compounding Medications Market


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X